COVID-19 and Influenza Coadministered Vaccines May Loiwer Risk of MACE in Older Adults
According to a recent study, coadministration of the COVID-19 vaccine with the annual influenza vaccine may reduce COVID-19-related major adverse cardiovascular events (MACE) among older adults, especially those with comorbidities. In the study, researchers conducted a target trial emulation using electronic health record data of more than one million veterans (mean age, 70 years; 92 […]
COVID-19 Vaccines Lower Risk of Heart Attack and Cardiac Death
ccording to three different studies, COVID-19 vaccines were associated with a lower risk of major adverse cardiovascular events (MACE), in addition to other outcomes, particularly among older adults.
Study Finds Moderna and Pfizer/BioNTech COVID-19 Vaccines 70 to 76 Percent Effective Against Severe Illness in Kids
A recent study in Taiwan that examined the vaccine effectiveness (VE) against moderate to severe COVID-19 infection in children aged 6 to 11 years found the Pfizer/BioNTech BNT162b2 VE was 69.9 percent and the Moderna mRNA-1273 VE was 75.5 percent during Omicron BA.2/BA.5 predominance in 2022.
WHO and CDC: Preparing for the Next Pandemic
Changes to guidance from the WHO and CDC should strengthen preparedness and response to future potential pandemic diseases.
Researchers Discover Why a Rare Blood Clot Occurs After COVID-19 Vaccination
Researchers have discovered why the unusual side effect of a blood clot that impacted some recipients of the Oxford/AstraZeneca and Johnson & Johnson COVID-19 vaccines occurred.
Vaccine Against SARS Virus Family Enters Human Clinical Trials
A vaccine candidate called GBP511 that builds upon a self-assembling nanoparticle technology has begun human clinical testing in Australia.
SARS-CoV-2 and COVID-19: Plasma Supply and IG Replacement Therapy to Protect Immunodeficient Patients
Can anti-SARS-CoV-2 antibodies in the plasma supply protect against COVID infection in
immunodeficient patients? Research suggests otherwise.
Study Shows No Causal Relationship Between COVID-19 Vaccination and Myositis
According to a study that analyzed the Veteran’s Health Administration records found there is no evidence to suggest COVID-19 vaccination increases the risk of developing idiopathic inflammatory myositis.
Huge Study Shows mRNA COVID Vaccines Associated with 25 Percent Lower Risk Of Death From Any Cause
In a national cohort study of 28 million individuals, researchers found no increased risk of four-year all-cause mortality in individuals aged 18 to 59 years vaccinated against COVID-19, further supporting the safety of the mRNA vaccines that are widely used worldwide.
COVID-19 Vaccine Tied to Increased Survival in Patients with Cancer
A study has found that for patients with certain types of advanced lung or skin cancer, administration of a SARS-CoV-2 mRNA vaccine within 100 days of starting immune checkpoint inhibitors is associated with increased overall survival.